Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
A low 25-hydroxyvitamin D (25(OH)D) level is considered as an independent risk factor for COVID-19 severity. However, the association between vitamin D status and outcomes in COVID-19 is controversial. In the present study we investigate the association between the serum 25(OH)D level, immune respon...
Main Authors: | Tatiana L. Karonova, Igor V. Kudryavtsev, Ksenia A. Golovatyuk, Arthur D. Aquino, Olga V. Kalinina, Alena T. Chernikova, Ekaterina K. Zaikova, Denis A. Lebedev, Ekaterina S. Bykova, Alexey S. Golovkin, Evgeny V. Shlyakhto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/3/305 |
Similar Items
-
Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study
by: Tatiana L. Karonova, et al.
Published: (2022-06-01) -
Vitamin D Intake May Reduce SARS-CoV-2 Infection Morbidity in Health Care Workers
by: Tatiana L. Karonova, et al.
Published: (2022-01-01) -
Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19
by: Tatiana L. Karonova, et al.
Published: (2021-08-01) -
Vitamin D in Follicular Fluid Correlates With the Euploid Status of Blastocysts in a Vitamin D Deficient Population
by: Ana Arnanz, et al.
Published: (2021-01-01) -
Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19
by: Alexey Golovkin, et al.
Published: (2021-09-01)